A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands

Nucleic Acids Research

Volumn 44, Issue 18, 2016, Pages 8682-8692

  Kong, Lingchun ^a   Tan, Li ^a   Lv, Ruitu ^a   Shi, Zhennan ^a   Xiong, Lijun ^a   Wu, Feizhen ^a   Rabidou, Kimberlie ^b   Smith, Michael ^b   He, Celestine ^b   Zhang, Lei ^a   Qian, Yanyan ^a   Ma, Duan ^a   Lan, Fei ^a   Shi, Yang ^a,c   Shi, Yujiang Geno ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; METHYL CPG BINDING PROTEIN 2; TEN ELEVEN TRANSLOCATION PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HISTONE; LYSINE; ONCOPROTEIN; TET1 PROTEIN, MOUSE; TET2 PROTEIN, HUMAN; TET2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CPG ISLAND; DNA MODIFICATION; EMBRYO; EPIGENETICS; GAIN OF FUNCTION MUTATION; GENETIC TRANSCRIPTION; GENOME-WIDE ASSOCIATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTONE DEMETHYLATION; HISTONE MODIFICATION; IMMUNOFLUORESCENCE; LOSS OF FUNCTION MUTATION; MASS SPECTROMETRY; MOLECULAR INTERACTION; MOUSE; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOLOGICAL MODEL; DNA METHYLATION; EMBRYONIC STEM CELL; GENETICS; GENOME; HEK293 CELL LINE; HUMAN; METABOLISM;

ANIMALS; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; GENOME; HEK293 CELLS; HISTONES; HUMANS; LYSINE; MICE; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84992322851     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw529     Document Type: Article

References (55)

1. Bernstein B.E, Meissner A, and Lander E.S. (2007). The mammalian epigenome. Cell, 128, 669-681.
2. Suzuki M.M, and Bird A. (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet, 9, 465-476.
3. Meissner A. (2011). Guiding DNA methylation. Cell Stem Cell, 9, 388-390.
4. Meissner A. (2010) Epigenetic modifications in pluripotent and differentiated cells. Nat. Biotechnol, 28, 1079-1088.
5. Lennartsson A, and Ekwall K. (2009). Histone modification patterns and epigenetic codes. Biochim et Biophys. Acta, 1790, 863-868.
6. Cedar H, and Bergman Y. (2009). Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet, 10, 295-304.
7. Jones P.L, Veenstra G.J, Wade P.A, Vermaak D, Kass S.U, Landsberger N, Strouboulis J, and Wolffe A.P. (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet, 19, 187-191.
8. Ooi S.K, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin S.P, Allis C.D, et al. (2007). DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature, 448, 714-717.
9. Guenther M.G, Levine S.S, Boyer L.A, Jaenisch R, and Young R.A. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell, 130, 77-88.
10. Santos-Rosa H, Schneider R, Bannister A.J, Sherriff J, Bernstein B.E, Emre N.C, Schreiber S.L, Mellor J, and Kouzarides T. (2002). Active genes are tri-methylated at K4 of histone H3. Nature, 419, 407-411.
11. Bracken A.P, Dietrich N, Pasini D, Hansen K.H, and Helin K. (2006). Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev, 20, 1123-1136.
12. Bernstein B.E, Mikkelsen T.S, Xie X, Kamal M, Huebert D.J, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell, 125, 315-326.
13. Cui K, Zang C, Roh T.Y, Schones D.E, Childs R.W, Peng W, and Zhao K. (2009). Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell, 4, 80-93.
14. Rodriguez J, Munoz M, Vives L, Frangou C.G, Groudine M, and Peinado M.A. (2008). Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc. Natl. Acad. Sci. U.S.A, 105, 19809-19814.
15. Simmer F, Brinkman A.B, Assenov Y, Matarese F, Kaan A, Sabatino L, Villanueva A, Huertas D, Esteller M, Lengauer T, et al. (2012). Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics, 7, 1355-1367.
16. Young M.D, Willson T.A, Wakefield M.J, Trounson E, Hilton D.J, Blewitt M.E, Oshlack A, and Majewski I.J. (2011). ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity. Nucleic Acids Res, 39, 7415-7427.
17. Pauler F.M, Sloane M.A, Huang R, Regha K, Koerner M.V, Tamir I, Sommer A, Aszodi A, Jenuwein T, and Barlow D.P. (2009). H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res, 19, 221-233.
18. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir G.A, Stewart R, and Thomson J.A. (2007). Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell, 1, 299-312.
19. Boyer L.A, Plath K, Zeitlinger J, Brambrink T, Medeiros L.A, Lee T.I, Levine S.S, Wernig M, Tajonar A, Ray M.K, et al. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature, 441, 349-353.
20. Meissner A, Mikkelsen T.S, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein B.E, Nusbaum C, Jaffe D.B, et al. (2008). Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature, 454, 766-770.
21. Mikkelsen T.S, Ku M, Jaffe D.B, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim T.K, Koche R.P, et al. (2007). Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 448, 553-560.
22. Voigt P, Tee W.W, and Reinberg D. (2013). A double take on bivalent promoters. Genes Dev, 27, 1318-1338.
23. Mendenhall E.M, Koche R.P, Truong T, Zhou V.W, Issac B, Chi A.S, Ku M, and Bernstein B.E. (2010). GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet, 6, e1001244.
24. Woo C.J, Kharchenko P.V, Daheron L, Park P.J, and Kingston R.E. (2010). A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell, 140, 99-110.
25. Lynch M.D, Smith A.J, De Gobbi M, Flenley M, Hughes J.R, Vernimmen D, Ayyub H, Sharpe J.A, Sloane-Stanley J.A, Sutherland L, et al. (2012). An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment. EMBO J, 31, 317-329.
26. Iyer L.M, Tahiliani M, Rao A, and Aravind L. (2009). Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle, 8, 1698-1710.
27. He Y.F, Li B.Z, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science, 333, 1303-1307.
28. Ito S, Shen L, Dai Q, Wu S.C, Collins L.B, Swenberg J.A, He C, and Zhang Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science, 333, 1300-1303.
29. Tan L, and Shi Y.G. (2012). Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development, 139, 1895-1902.
30. Yusa K, Rad R, Takeda J, and Bradley A. (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods, 6, 363-369.
31. Woltjen K, Michael I.P, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M, et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458, 766-770.
32. Zhang H, Zhang X, Clark E, Mulcahey M, Huang S, and Shi Y.G. (2010). TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res, 20, 1390-1393.
33. Tan L, Xiong L, Xu W, Wu F, Huang N, Xu Y, Kong L, Zheng L, Schwartz L, Shi Y, et al. (2013). Genome-wide comparison of DNA hydroxymethylation in mouse embryonic stem cells and neural progenitor cells by a new comparative hMeDIP-seq method. Nucleic Acids Res, 41, e84.
34. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera A.J, Zheng L, Zhang H, Huang S, et al. (2011). Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell, 42, 451-464.
35. Huang da W, Sherman B.T, and Lempicki R.A. (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37, 1-13.
36. Robinson M.D, Stirzaker C, Statham A.L, Coolen M.W, Song J.Z, Nair S.S, Strbenac D, Speed T.P, and Clark S.J. (2010). Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation. Genome Res, 20, 1719-1729.
37. Ehrich M, Nelson M.R, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor C.R, Field J.K, and van den Boom D. (2005). Quantitative high-Throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A, 102, 15785-15790.
38. Schubeler D, Lorincz M.C, Cimbora D.M, Telling A, Feng Y.Q, Bouhassira E.E, and Groudine M. (2000). Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol. Cell. Biol, 20, 9103-9112.
39. Clouaire T, Webb S, Skene P, Illingworth R, Kerr A, Andrews R, Lee J.H, Skalnik D, and Bird A. (2012). Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev, 26, 1714-1728.
40. Reddington J.P, Perricone S.M, Nestor C.E, Reichmann J, Youngson N.A, Suzuki M, Reinhardt D, Dunican D.S, Prendergast J.G, Mjoseng H, et al. (2013). Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Genome Biol, 14, R25.
41. Yuan W, Wu T, Fu H, Dai C, Wu H, Liu N, Li X, Xu M, Zhang Z, Niu T, et al. (2012). Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science, 337, 971-975.
42. Mayor R, Munoz M, Coolen M.W, Custodio J, Esteller M, Clark S.J, and Peinado M.A. (2011). Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. Epigenetics, 6, 1138-1148.
43. Tahiliani M, Koh K.P, Shen Y, Pastor W.A, Bandukwala H, Brudno Y, Agarwal S, Iyer L.M, Liu D.R, Aravind L, et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 324, 930-935.
44. Fouse S.D, Shen Y, Pellegrini M, Cole S, Meissner A, Van Neste L, Jaenisch R, and Fan G. (2008). Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell, 2, 160-169.
45. Williams K, Christensen J, and Helin K. (2012). DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep, 13, 28-35.
46. Grosser C, Wagner N, Grothaus K, and Horsthemke B. (2015). Altering TET dioxygenase levels within physiological range affects DNA methylation dynamics of HEK293 cells. Epigenetics, 10, 819-833.
47. Jin C, Lu Y, Jelinek J, Liang S, Estecio M.R, Barton M.C, and Issa J.P. (2014). TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic Acids Res, 42, 6956-6971.
48. Deplus R, Delatte B, Schwinn M.K, Defrance M, Mendez J, Murphy N, Dawson M.A, Volkmar M, Putmans P, Calonne E, et al. (2013). TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J, 32, 645-655.
49. Hu X, Zhang L, Mao S.Q, Li Z, Chen J, Zhang R.R, Wu H.P, Gao J, Guo F, Liu W, et al. (2014). Tet and TDG mediate DNA demethylation essential for mesenchymal-To-epithelial transition in somatic cell reprogramming. Cell Stem Cell, 14, 512-522.
50. Dawlaty M.M, Breiling A, Le T, Barrasa M.I, Raddatz G, Gao Q, Powell B.E, Cheng A.W, Faull K.F, Lyko F, et al. (2014). Loss of Tet enzymes compromises proper differentiation of embryonic stem cells. Dev. Cell, 29, 102-111.
51. Ehrlich M. (2002). DNA methylation in cancer: too much, but also too little. Oncogene, 21, 5400-5413.
52. Easwaran H, Johnstone S.E, Van Neste L, Ohm J, Mosbruger T, Wang Q, Aryee M.J, Joyce P, Ahuja N, Weisenberger D, et al. (2012). A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res, 22, 837-849.
53. Yang H, Liu Y, Bai F, Zhang J.Y, Ma S.H, Liu J, Xu Z.D, Zhu H.G, Ling Z.Q, Ye D, et al. (2013). Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene, 32, 663-669.
54. Li W, and Liu M. (2011). Distribution of 5-hydroxymethylcytosine in different human tissues. J. Nucleic Acids, 870726.
55. Lian C.G, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. (2012). Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell, 150, 1135-1146.